{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:41:24Z","timestamp":1789472484985,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Overactive bladder (OAB) is a symptom-defined syndrome, and its metabolic correlates remain incompletely understood. This study investigated whether urinary tricarboxylic acid cycle metabolites differ between women with symptom-defined probable OAB and controls without clinically recognized cardiometabolic disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional clinic-based study, women aged 18 years and older attending a gynecology outpatient clinic were enrolled. Participants with self-reported cardiometabolic disease or related medication use were excluded. Probable OAB was defined by an Overactive Bladder Awareness Tool Version 8 score of 8 or higher. Midstream urine samples were analyzed for succinate and malate by gas chromatography-mass spectrometry and normalized to urinary creatinine. Group comparisons, Spearman correlations, multivariable log-linear regression, sensitivity analyses, and exploratory receiver operating characteristic analyses were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 186 women were included, comprising 81 with OAB and 105 controls. Women with OAB were older, had slightly higher body mass index, higher parity, and were more frequently postmenopausal. Urinary succinate and malate levels were higher in the OAB group. After adjustment for age, body mass index, parity, and menopausal status, OAB remained associated with higher urinary succinate (adjusted geometric mean ratio, 1.69; 95% CI, 1.34\u20132.12) and malate (1.25; 95% CI, 1.02\u20131.52). Succinate showed modest exploratory discrimination (AUC, 0.678), whereas malate showed limited discrimination (AUC, 0.560).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Urinary succinate was higher in women with symptom-defined probable OAB even after adjustment for major demographic covariates, while the association with malate was weaker. These findings are hypothesis-generating and require confirmation in adequately powered, prospectively phenotyped cohorts with standardized metabolic, dietary, and urinary microbiome assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-026-04596-8","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:33:23Z","timestamp":1782452003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elevated urinary succinate in women with symptom-defined overactive bladder without clinically recognized cardiometabolic disease: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"\u00d6mer Faruk","family":"\u00d6z","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Murat","family":"Seval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulut","family":"Varli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eerife Esra","family":"\u00c7etinkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulya","family":"D\u00f6kmeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"1","key":"4596_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/nau.20798","volume":"29","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK. An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodynamics: Official J Int Cont Soc. 2010;29(1):4\u201320.","journal-title":"Neurourol Urodynamics: Official J Int Cont Soc"},{"issue":"6","key":"4596_CR2","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306\u201315.","journal-title":"Eur Urol"},{"issue":"8","key":"4596_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00192-024-06029-2","volume":"36","author":"L Zhang","year":"2025","unstructured":"Zhang L, Cai N, Mo L, Tian X, Liu H, Yu B. Global prevalence of overactive bladder: a systematic review and meta-analysis. Int Urogynecol J. 2025;36(8):1547\u201366. https:\/\/doi.org\/10.1007\/s00192-024-06029-2.","journal-title":"Int Urogynecol J"},{"key":"4596_CR4","doi-asserted-by":"publisher","unstructured":"Xie H, Liang Y, Zhao X, Liu H, Xu Y, Zhang H. Prevalence and trends in overactive bladder among women in the United States, 2005\u20132020. Int Urogynecol J. 2025 Nov;12. https:\/\/doi.org\/10.1007\/s00192-025-06419-0.","DOI":"10.1007\/s00192-025-06419-0"},{"issue":"5","key":"4596_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0302-2838(03)00097-6","volume":"43","author":"F Chiaffarino","year":"2003","unstructured":"Chiaffarino F, Parazzini F, Lavezzari M, Giambanco V. Impact of urinary incontinence and overactive bladder on quality of life. Eur Urol. 2003;43(5):535\u20138.","journal-title":"Eur Urol"},{"issue":"3","key":"4596_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrurol.2011.7","volume":"8","author":"R Cartwright","year":"2011","unstructured":"Cartwright R, Afshan I, Derpapas A, Vijaya G, Khullar V. Novel biomarkers for overactive bladder. Nat Reviews Urol. 2011;8(3):139\u201345.","journal-title":"Nat Reviews Urol"},{"issue":"1","key":"4596_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1442-2042.2007.01907.x","volume":"15","author":"Y Homma","year":"2008","unstructured":"Homma Y. Lower urinary tract symptomatology: Its definition and confusion. Int J Urol. 2008;15(1):35\u201343.","journal-title":"Int J Urol"},{"issue":"5","key":"4596_CR8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00192-019-04175-6","volume":"31","author":"AH Mossa","year":"2020","unstructured":"Mossa AH, Shamout S, Cammisotto P, Campeau L. Urinary metabolomics predict the severity of overactive bladder syndrome in an aging female population. Int Urogynecol J. 2020;31(5):1023\u201331.","journal-title":"Int Urogynecol J"},{"issue":"2","key":"4596_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11255-013-0540-x","volume":"46","author":"L-w Wang","year":"2014","unstructured":"Wang L-w, Han X-m, Chen C-h, Ma Y, Hai B. Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder. Int Urol Nephrol. 2014;46(2):341\u20137.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"4596_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11255-009-9647-5","volume":"42","author":"P Tyagi","year":"2010","unstructured":"Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, Vodovotz Y, Chancellor M. Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol. 2010;42(3):629\u201335.","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"4596_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5213\/inj.1732794.397","volume":"21","author":"YS Suh","year":"2017","unstructured":"Suh YS, Ko KJ, Kim TH, Lee HS, Sung HH, Cho WJ, Lee K-S. Urinary nerve growth factor as a potential biomarker of treatment outcomes in overactive bladder patients. Int Neurourol J. 2017;21(4):270.","journal-title":"Int Neurourol J"},{"issue":"6","key":"4596_CR12","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1113\/EP088450","volume":"105","author":"S Firouzmand","year":"2020","unstructured":"Firouzmand S, Young JS. A pilot study to investigate the associations of urinary concentrations of NO, ATP and derivatives with overactive bladder symptom severity. Exp Physiol. 2020;105(6):932\u20139.","journal-title":"Exp Physiol"},{"issue":"1","key":"4596_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000365682","volume":"8","author":"PB Patra","year":"2015","unstructured":"Patra PB, Patra S. Research findings on overactive bladder. Curr Urol. 2015;8(1):1\u201321.","journal-title":"Curr Urol"},{"issue":"11","key":"4596_CR14","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1021\/pr200514h","volume":"10","author":"S Tulipani","year":"2011","unstructured":"Tulipani S, Llorach R, J\u00e1uregui O, L\u00f3pez-Uriarte P, Garcia-Aloy M, Bullo M, Salas-Salvad\u00f3 J, Andr\u00e9s-Lacueva C. Metabolomics unveils urinary changes in subjects with metabolic syndrome following 12-week nut consumption. J Proteome Res. 2011;10(11):5047\u201358.","journal-title":"J Proteome Res"},{"issue":"1","key":"4596_CR15","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1038\/s41598-025-90438-w","volume":"15","author":"Z Li","year":"2025","unstructured":"Li Z, Liu X, Li Y, Chen X, Liu Z, Gao X, Cui J. Association between cardiovascular health and overactive bladder. Sci Rep. 2025;15(1):5760.","journal-title":"Sci Rep"},{"issue":"1","key":"4596_CR16","doi-asserted-by":"publisher","first-page":"11842","DOI":"10.1038\/s41598-024-62842-1","volume":"14","author":"G Feng","year":"2024","unstructured":"Feng G, Huang S, Zhao W, Gong H. Association between life\u2019s essential 8 and overactive bladder. Sci Rep. 2024;14(1):11842.","journal-title":"Sci Rep"},{"key":"4596_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cellsig.2017.05.014","volume":"37","author":"AH Mossa","year":"2017","unstructured":"Mossa AH, Flores MV, Cammisotto PG, Campeau L. Succinate, increased in metabolic syndrome, activates GPR91 receptor signaling in urothelial cells. Cell Signal. 2017;37:31\u20139.","journal-title":"Cell Signal"},{"issue":"5","key":"4596_CR18","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/nau.23488","volume":"37","author":"M Velasquez Flores","year":"2018","unstructured":"Velasquez Flores M, Mossa AH, Cammisotto P, Campeau L. Succinate decreases bladder function in a rat model associated with metabolic syndrome. Neurourol Urodyn. 2018;37(5):1549\u201358.","journal-title":"Neurourol Urodyn"},{"key":"4596_CR19","doi-asserted-by":"publisher","first-page":"1266973","DOI":"10.3389\/fcell.2023.1266973","volume":"11","author":"W Zhang","year":"2023","unstructured":"Zhang W, Lang R. Succinate metabolism: a promising therapeutic target for inflammation, ischemia\/reperfusion injury and cancer. Front Cell Dev Biology. 2023;11:1266973.","journal-title":"Front Cell Dev Biology"},{"issue":"2","key":"4596_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1124\/jpet.118.249979","volume":"367","author":"A Mossa","year":"2018","unstructured":"Mossa A, Flores MV, Nguyen H, Cammisotto PG, Campeau L. Beta-3 adrenoceptor signaling pathways in urothelial and smooth muscle cells in the presence of succinate. J Pharmacol Exp Ther. 2018;367(2):252\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"4596_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/nau.24553","volume":"40","author":"A Mossa","year":"2021","unstructured":"Mossa A, Velasquez-Flores M, Cammisotto PG, Campeau L. Receptor GPR91 contributes to voiding function and detrusor relaxation mediated by succinate. Neurourol Urodyn. 2021;40(1):120\u201330.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"4596_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/BF02850085","volume":"22","author":"KS Coyne","year":"2005","unstructured":"Coyne KS, Zyczynski T, Margolis MK, Elinoff V, Roberts RG. Validation of an overactive bladder awareness tool for use in primary care settings. Adv therapy. 2005;22(4):381\u201394.","journal-title":"Adv therapy"},{"issue":"21","key":"4596_CR23","first-page":"113","volume":"21","author":"T Tarcan","year":"2012","unstructured":"Tarcan T, Mang\u0131r N, \u00d6zg\u00fcr M\u00d6, Akbal C. OAB-V8 A\u015f\u0131r\u0131 aktif mesane sorgulama formu validasyon \u00e7al\u0131\u015fmas\u0131. \u00dcroloji B\u00fclteni. 2012;21(21):113\u20136.","journal-title":"\u00dcroloji B\u00fclteni"},{"issue":"1","key":"4596_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/nau.20292","volume":"26","author":"C Cam","year":"2007","unstructured":"Cam C, Sakalli M, Ay P, Cam M, Karateke A. Validation of the short forms of the incontinence impact questionnaire (IIQ-7) and the urogenital distress inventory (UDI\u20106) in a Turkish population. Neurourol Urodynamics: Official J Int Cont Soc. 2007;26(1):129\u201333.","journal-title":"Neurourol Urodynamics: Official J Int Cont Soc"},{"issue":"2","key":"4596_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/nau.1930140206","volume":"14","author":"JS Uebersax","year":"1995","unstructured":"Uebersax JS, Wyman JF, Shumaker SA, McClish DK. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Neurourol Urodyn. 1995;14(2):131\u20139.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"4596_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/(SICI)1520-6777(2000)19:2<137::AID-NAU4>3.0.CO;2-G","volume":"19","author":"H Sandvik","year":"2000","unstructured":"Sandvik H, Seim A, Vanvik A, Hunskaar S. A severity index for epidemiological surveys of female urinary incontinence: comparison with 48-hour pad\u2010weighing tests. Neurourol Urodynamics: Official J Int Cont Soc. 2000;19(2):137\u201345.","journal-title":"Neurourol Urodynamics: Official J Int Cont Soc"},{"issue":"3","key":"4596_CR27","first-page":"5","volume":"9","author":"HU Hazar","year":"2008","unstructured":"Hazar HU, \u015eirin A. A validity and reliablity study of the incontinence index. Meandros Med Dent J. 2008;9(3):5\u20138.","journal-title":"Meandros Med Dent J"},{"issue":"4","key":"4596_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.orcp.2007.10.001","volume":"1","author":"S Tanyola\u00e7","year":"2007","unstructured":"Tanyola\u00e7 S, C\u0131k\u0131m AS, Azezli AD, Orhan Y. The alarm and action levels of waist circumference in overweight and obese Turkish women. Obes Res Clin Pract. 2007;1(4):253\u20139.","journal-title":"Obes Res Clin Pract"},{"issue":"16","key":"4596_CR29","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation"},{"issue":"5\u20136","key":"4596_CR30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.mito.2004.07.010","volume":"4","author":"BA Barshop","year":"2004","unstructured":"Barshop BA. Metabolomic approaches to mitochondrial disease: correlation of urine organic acids. Mitochondrion. 2004;4(5\u20136):521\u20137.","journal-title":"Mitochondrion"},{"issue":"1","key":"4596_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3892\/ijmm.2017.2983","volume":"40","author":"D Tsoukalas","year":"2017","unstructured":"Tsoukalas D, Alegakis A, Fragkiadaki P, Papakonstantinou E, Nikitovic D, Karataraki A, et al. Application of metabolomics: Focus on the quantification of organic acids in healthy adults. Int J Mol Med. 2017;40(1):112\u201320. https:\/\/doi.org\/10.3892\/ijmm.2017.2983.","journal-title":"Int J Mol Med"},{"issue":"8","key":"4596_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/metabo9080156","volume":"9","author":"VL Stevens","year":"2019","unstructured":"Stevens VL, Hoover E, Wang Y, Zanetti KA. Pre-analytical factors that affect metabolite stability in human urine, plasma, and serum: a review. Metabolites. 2019;9(8):156. https:\/\/doi.org\/10.3390\/metabo9080156.","journal-title":"Metabolites"},{"issue":"4","key":"4596_CR33","doi-asserted-by":"publisher","first-page":"e01283","DOI":"10.1128\/mBio.01283-14","volume":"5","author":"MM Pearce","year":"2014","unstructured":"Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C, et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014;5(4):e01283\u201314. https:\/\/doi.org\/10.1128\/mBio.01283-14.","journal-title":"mBio"},{"issue":"3","key":"4596_CR34","doi-asserted-by":"publisher","first-page":"347e","DOI":"10.1016\/j.ajog.2015.07.009","volume":"213","author":"MM Pearce","year":"2015","unstructured":"Pearce MM, Zilliox MJ, Rosenfeld AB, Thomas-White KJ, Richter HE, Nager CW, et al. The female urinary microbiome in urgency urinary incontinence. Am J Obstet Gynecol. 2015;213(3):347e. 1-347.e11.","journal-title":"Am J Obstet Gynecol"},{"key":"4596_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fcimb.2016.00078","volume":"6","author":"L Karstens","year":"2016","unstructured":"Karstens L, Asquith M, Davin S, Stauffer P, Fair D, Gregory WT, et al. Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Front Cell Infect Microbiol. 2016;6:78. https:\/\/doi.org\/10.3389\/fcimb.2016.00078.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4596_CR36","doi-asserted-by":"publisher","first-page":"2190300","DOI":"10.1080\/19490976.2023.2190300","volume":"15","author":"Y Wei","year":"2023","unstructured":"Wei Y, Li Y, Yan L, Sun C, Miao Q, Wang Q, et al. Succinate metabolism and its regulation of host-microbe interactions. Gut Microbes. 2023;15(1):2190300. https:\/\/doi.org\/10.1080\/19490976.2023.2190300.","journal-title":"Gut Microbes"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04596-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04596-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04596-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:13:30Z","timestamp":1789082010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04596-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4596"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04596-8","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. The study protocol was approved by the Ankara University School of Medicine Ethics Committee (No: 13-208-21). Written informed consent to participate was obtained from all participants before enrollment.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"450"}}